News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotech Medical Corporation Well-Positioned to Immediately Respond to Swine Flu Emergency with SDC-Based SpectraSan 24 Disinfectant


4/27/2009 9:16:31 AM

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (NASDAQ: PURE), creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that its distributor, BioTech Medical, LLC, is well-positioned to immediately respond to the current swine flu emergency with its SDC-based SpectraSan 24™ disinfectant. SpectraSan 24 meets the recommendations by the United States Centers for Disease Control (CDC) for infection control for care of patients with confirmed or suspected Swine Influenza A (H1N1) virus in both home and healthcare settings.

Read at BioSpace.com


comments powered by Disqus
   
Swine Flu

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES